Connect Biopharma Holdings (CNTB) Cash & Equivalents (2020 - 2026)
Connect Biopharma Holdings (CNTB) recorded Cash & Equivalents of $27.02 million in Q2 2026, down 33.5% from $40.63 million a year earlier and down 41.3% from the prior quarter.
Connect Biopharma Holdings (CNTB) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, Connect Biopharma Holdings reported Cash & Equivalents of $38.35 million, down 51.0% from FY2024.
- Annual Cash & Equivalents has a five-year compound annual growth rate of -24.1% (FY2020 to FY2025).
- Across earlier years, Cash & Equivalents came in at $78.23 million in FY2024 (-26.0%), $105.66 million in FY2023 (+33.7%), $79.01 million in FY2022 (-70.5%) and $267.72 million in FY2021 (+75.7%).
- The Q2 2026 figure is the lowest quarterly Cash & Equivalents in data going back to Q4 2020.
- On a year-over-year basis, Cash & Equivalents has declined for three consecutive quarters, with an average decline of 35.4% over the last five quarters.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 75.2% in Q4 2021, against a decline of 71.0% in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $46.03 million (Q1 2026), $38.35 million (Q4 2025) and $37.85 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Connect Biopharma Holdings | 47.86 Mn | -128.81 Mn | - | 27.02 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.02 Mn |
| Mar 31, 2026 | 46.03 Mn |
| Dec 31, 2025 | 38.35 Mn |
| Sep 30, 2025 | 37.85 Mn |
| Jun 30, 2025 | 40.63 Mn |
| Mar 31, 2025 | 47.71 Mn |
| Dec 31, 2024 | 78.23 Mn |
| Jun 30, 2024 | 110.20 Mn |
| Dec 31, 2023 | 105.66 Mn |
| Jun 30, 2023 | 81.61 Mn |
| Dec 31, 2022 | 79.03 Mn |
| Jun 30, 2022 | 141.37 Mn |
| Dec 31, 2021 | 267.87 Mn |
| Dec 31, 2020 | 154.87 Mn |
Connect Biopharma Holdings Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CNTB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "CNTB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CNTB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();